Innovative therapies for asthma: Anti-IgE - The future?

Paediatric Respiratory Reviews

Volumn 5, Issue SUPPL. A, 2004, Pages

  Weinberger, Miles ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID DERIVATIVE; IMMUNOGLOBULIN E ANTIBODY; OMALIZUMAB; PLACEBO; RHUMAB E25; SALMETEROL; THEOPHYLLINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CGP 51901; CORTICOSTEROID; HISTAMINE; IMMUNOGLOBULIN E; LEUKOTRIENE; LONG ACTING DRUG; MONOCLONAL ANTIBODY; REAGINIC ANTIBODY; SALBUTAMOL; STEROID; UNCLASSIFIED DRUG;

ARTICLE; ASTHMA; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG BINDING; DRUG DESIGN; DRUG EFFICACY; DRUG MARKETING; FLUSHING; HUMAN; IMMUNOTHERAPY; PRIORITY JOURNAL; PRURITUS; SIDE EFFECT; SINGLE DRUG DOSE; URTICARIA; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ALLERGY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG WITHDRAWAL; METERED DOSE INHALER; REVIEW; SKIN TEST; SLOW RELEASE FORMULATION;

EID: 1342287014     PISSN: 15260542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1526-0542(04)90022-X     Document Type: Review

References (16)

1. Ishizaka K, Ishizaka T, Hornbrook M. Physico-chemical properties of reaginic antibody. V. Correlation of reaginic activity with γE-globulin antibody. J Immunol 1966; 97: 840-853.
2. Stadler BM, Stampfli MR, Miescher S, Furukawa K, Vogel M. Biological activities of anti-IgE antibodies. Int Arch Allergy Immunol 1993; 102: 121-126.
3. Rudolph MP, Furukawa K, Miescher S, Vogel M, Kricek F, Stadler BM. Effect of anti-IgE antibodies on Fc epsilonRI-bound IgE. J Immunol 1996; 157: 5646-5652.
4. Corne J, Djukanovic R, Thomas L, Warner J, Botta L, Grandordy B, Gygax D, Heusser C, Patalano F, Richardson W, Kilcherr E, Staehelin T, Davis F, Gordon W, Sun L, Liou R, Wang G, Chang TW, Holgate S. The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety, and pharmacokinetics. J Clin Invest 1997; 99: 879-887.
5. Fahy JV, Fleming HE, Wong HH, Liu JT, Su JQ, Reimann J, Fick RB Jr, Boushey HA. The effect of an anti-IgE monoclonal antibody on the early- and late-phase response to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 1997; 155: 1828-1834.
6. Casale TB, Bernstein IL, Busse WW, La Force CF, Tinkelman DG, Stoltz RR, Reimann J, Su JQ, Fick RB, Adelman DC. Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. J Allergy Clin Immunol 1997; 100: 110-121.
7. Milgrom H, Fick RB, Su JQ, Reimann JD, Bush RK, Watrous ML, Metzger WJ. Treatment of allergic asthma with monoclonal anti-IgE antibody. N Engl J Med 1999; 341: 1966-1973.
8. Adelroth E, Rak S, Haahtela T, Assand G, Rosenhall L, Zetterstrom O, Byrne A, Champain K, Thirlwell J, Cioppa GD, Sandström T. Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis. J Allergy Clin Immunol 2000; 106: 253-259.
9. Casale TB, Condemi J, LaForce C, Nayak A, Rowe M, Watrous M, McAlary M, Fowler-Taylor A, Racine A, Gupta N, Fick R, Cioppa GD. Effect of omalizumab on symptoms of seasonal allergic rhinitis - a randomized controlled trial. JAMA 2001; 286: 2956-2967.
10. Kuehr J, Brauburger J, Zielen S, Schauer U, Kamin W, Von Berg A, Leupold W, Bergmann KC, Rolinck-Werninghaus C, Gräve M, Hultsch T, Wahn U. Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis. J Allergy Clin Immunol 2002; 109: 274-280.
11. Soler M, Matz J, Townley R, Buhl R, O'Brien J, Fox H, Thirlwell J, Gupta N, Cioppa GD. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. Eur Respir J 2001; 18: 254-261.
12. Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, Ciopa GD, van As A, Gupta N. Omalizumab, anti IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 2001; 108: 184-190.
13. Milgrom H, Berger W, Nayak A, Gupta N, Pollard S, McAlary M, Taylor AF, Rohane P. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab). Pediatrics 2001; 108(2). URL: http://www.pediatrics.org/cgi/content/full/108/2/e36.
14. Pearce N, Pekkanen J, Beasley R. How much asthma is really attributable to atopy? Thorax 1999; 54: 268-272.
15. Weinberger M. Salmeterol for the treatment of asthma. Ann Allergy 1995; 75: 209-211.
16. Weinberger M, Hendeles L. Theophylline in asthma. N Engl J Med 1996; 334: 1380-1388.